Xilio Therapeutics Inc. COM is a security (CUSIP 98422T100) tracked across SEC portfolio filings. 4 institutional managers reported $8.3M on Form 13F as of 2026-06-30.
| Manager | Location | Value | Shares |
|---|---|---|---|
| GILEAD SCIENCES, INC. | FOSTER CITY, CA | $6.2M | 650,389 |
| TAKEDA PHARMACEUTICAL CO LTD | Tokyo, M0 | $1.2M | 1,475,121 |
| VANGUARD GROUP INC | Valley Forge, PA | $804K | 1,255,692 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |